Indoco Remedies Reports Highest Net Sales Amid Declining Profitability and Rising Interest Costs in June 2025

Jul 24 2025 02:33 PM IST
share
Share Via
Indoco Remedies has reported its financial results for the quarter ending June 2025, showcasing the highest net sales in five quarters at Rs 437.89 crore. However, the company faces challenges with significant declines in both Profit Before Tax and Profit After Tax, alongside rising interest costs indicating potential liquidity issues.
Indoco Remedies, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently reported its financial results for the quarter ending June 2025. The evaluation changes reflect a notable shift in the company's score, which has moved to -18 from -30 over the past three months.

The financial data reveals that Indoco Remedies achieved its highest net sales in the last five quarters, reaching Rs 437.89 crore, indicating a positive near-term sales trend. However, the company faces significant challenges, as its Profit Before Tax (PBT) has recorded a substantial decline, standing at Rs -38.29 crore, which is markedly lower than the average PBT of the previous four quarters. Similarly, the Profit After Tax (PAT) has also seen a considerable drop, reported at Rs -35.79 crore, reflecting a negative near-term trend.

Additionally, the company has experienced a rise in interest costs, with quarterly interest reaching Rs 26.12 crore, marking a 45.27% increase quarter on quarter. This trend suggests that Indoco Remedies is increasing its borrowings to support operations, which may indicate a stressed liquidity situation.

For more insights, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News